• The National Pharmaceuticals Strategy is a comprehensive and collaborative pan-
Canadian approach to address problems related to affordability and safety.• Two new …

Parliament, a diverse group of experts at a recent symposium on pharmaceutical policies
endorsed the idea of a federally coordinated, national formulary of recommended drugs to …

Where you live in Canada and your economic status make a big difference to the sort of
prescription medicine you are likely to receive from public health insurance—although that is …

Background: The guiding principle of the Canada Health Act (CHA) is to provide Canadians
with “medically necessary care.” We note the historic limitations of the CHA with respect to …

Two decades ago Australia introduced an assessment of value as a prerequisite for adding
new medicines to its national drug formulary. Australia's program—a “fourth hurdle” process …

The Canadian federal government has proposed significant revisions to the way its patented
medicines price regulator assesses the excessiveness of medication prices that are to take …

This paper describes and assesses pharmaceutical pricing and reimbursement policies in
Canada, considering them in the context of the broader policy and market environment in …

• Although pharmaceuticals have the ability to improve health outcomes, they are the fastest
growing component of Canadian health care expenditures.• By analyzing the cost …

Canadian political leaders, regardless of ideology, have all learned to pledge allegiance to
the principle of a universal public health care system. But in terms of tangible commitments …

Background Approval times of new drugs are frequently longer in Canada than in the US,
but it has been argued that reducing approval times might lead to unsafe drugs receiving …